Comorbid Depression in Adult Oncology

Journal of Pharmacy Practice

Volumn 20, Issue 5, 2007, Pages 360-367

  Jackson, Cherry W ^a   Jackson, Kenneth H ^b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b Summit Cancer Center   (United States)

Author keywords

antidepressants; cancer; Depression; oncology

Indexed keywords

EID: 84990349889     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1177/0897190007304978     Document Type: Article

References (61)

1. National Cancer Institute. SEER Cancer Statistics Review, 1975-2002. 2006. Available at: http://seer.cancer.gov/csr/1975_2002/sections.html.
2. American Cancer Society. 2007 cancer statistics. Available at: http://www.cancer.org/docroot/stt/stt_0.asp.
3. Massie MJ, Holland JC Depression and the cancer patient. J Clin Psychiatry. 1990;51(suppl):12-19.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text-revised. Washington, DC: American Psychiatric Press; 2000.
5. Maguire P. Improving the detection of psychiatric problems in cancer patients. Soc Sci Med. 1985;20:819-823.
6. Hinton JM The psychiatry of terminal illness in adults and children. Proc R Soc Med. 1972;65:1035-1040.
7. Lansky S., List M., Herman C., et al. Absence of major depressive disorders in female cancer patients. J Clin Oncol. 1985; 3:1553-1560.
8. Derogatis LR, Morrow GR, Fetting J., et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983; 249;751-757.
9. Plumb M., Holland JC Comparative studies of psychological function in patients with advanced cancer: self-reported depressive symptoms. Psychosom Med. 1977;39:264-276.
10. Kathol RG, Mutgi A., William J., et al. Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiatry. 1990 ;147:1021-1024.
11. House A., Dennis M., Magridge L., et al. Mood disorders in the year after first stroke. Br J Psychiatry. 1991;158:83-92.
12. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med. 1989;149:1785-1789.
13. Bukberg J., Penman D., Holland JC Depression in hospitalized cancer patients. Psychosom Med. 1984;46:199-212.
14. Moffic HS, Paykel ES Depression in medical inpatients. Br J Psychiatry. 1975;127:346-353.
15. Katon W., Sullivan MD Depression and chronic medical illness. J Clin Psychiatry. 1990;51:3-11.
16. Hardman A., Maguire P., Crowther D., et al. The recognition of psychiatric morbidity on a medical oncology ward. J Psychosom Res. 1989;33:235-239.
17. Passik SD, Dugan W., McDonald MV Oncologists' recognition of depression in their patients with cancer. J Clin Oncol. 1998;16:1594-1600.
18. Kisely SR, Goldberg DP Physical and psychiatric co-morbidity in general practice. Br J Psychiatry. 1996;169:236-242.
19. Roy A. Suicides in depressives. Comp Psychiatry. 1983;24: 487-491.
20. Breitbart W., Wein SE Metabolic disorders and neuropsychiatric symptoms. In: Holland JC, Breitbart W, Jacobsen PB, et al, eds. Psycho-oncology. New York, NY: Oxford University Press; 1998:639-653.
21. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB Depression in patients with cancer: diagnosis, biology and treatment. Arch Gen Psychiatry. 1995;52:89-99.
22. Roth AJ, Holland JC Psychiatric complications in cancer patients. In: Brain MS, Carbone PP, eds. Current Therapy in Hematology-Oncology. 5th ed. St. Louis, MO: Mosby-Year Book; 1995:609-618.
23. Holland JC, Breitbart W, Jacobsen PB, et al, eds. Psychooncology. New York, NY: Oxford University Press; 1998.
24. Roth AJ, Holland JC Treatment of depression in cancer patients. Primary Care Cancer. 1994;14:23-29.
25. Green AI, Austin CP Psychopathology of pancreatic cancer. Psychosomatics. 1993;34:208-221.
26. Spiegel D., Sands S., Koopman C. Pain and depression in patients with cancer. Cancer. 1994;74:2570-2578.
27. Zigmond AS, Snaith RP The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370.
28. Morasso G., Costantini M., Baracco G., et al. Assessing psychological distress in cancer patients: validation of a self-administered questionnaire. Oncology. 1996;53:295-302.
29. Lloyd-Williams M., Riddleston H. The stability of depression scores in patients who are receiving palliative care. J Pain Symptom Manage. 2002;24:593-597.
30. Roth AJ, Kornblith AB, Bastel-Copel L., et al. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998;82:1094-1098.
31. Deogatis LR, Melisaratos N. The Brief Symptoms Inventory: an introductory report. Psychol Med. 1983;13:595-605.
32. Dugan W., McDonald MV, Passik SD, et al. Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool. Psychooncology. 1998;7:483-493.
33. Akizuki N., Yamawaki S., Akechi T., et al. Development of an impact thermometer for use in combination with the distress thermometer as a brief screening tool for adjustment disorders and/or major depression in cancer patients. J Pain Symptom Manage. 2005;29:91-99.
34. Meyer HA, Sinnott C., Seed PT Depressive symptoms in advanced cancer: Part 1. Assessing depression: the Mood Evaluation Questionnaire. Palliat Med. 2003;17:596-603.
35. McIntosh JL Suicide prevention in the elderly. Suicide Life Therat Behav. 1995;25:180-192.
36. Moscicki EK Identification of suicide risk factors using epidemiologic studies. Psychiatr Clin North Am. 1997;20:499-517.
37. Chochinov HM, Wilson KG, Enns M., et al. Prevalence of depression in the terminally ill: effects of diagnostic criteria and symptom threshold judgements. Am J Psychiatry. 1994: 151:537-540.
38. Bolund C. Suicide and cancer: I. Demographic and social characteristics of cancer patients who committed suicide in Sweden. J Psychosoc Oncol. 1985 ;3:17-30.
39. Bolund C. Suicide and cancer: II. Medical and care factors in suicides by cancer patients in Sweden. J Psychosoc Oncol. 1985;3:31-52.
40. Massie MJ, Gagnon P., Holland JC Depression and suicide in patients with cancer. J Pain Symptoms Manage. 1994;9: 325-340.
41. Lebowitz BC, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late life: consensus statement update. JAMA. 1997;278:1186-1190.
42. Pearson JL, Conwell Y., Lyness JM Late-life suicide and depression in the primary care setting. N Dir Ment Health Serv. 1997;76:13-38.
43. Wilson KG, Scott JF, Graham ID, et al. Attitudes of terminally ill patients toward euthanasia and physician-assisted suicide. Arch Intern Med. 2000;160:2454-2460.
44. Devine EC, Westlake SK The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies. Oncol Nurs Forum. 1995;22:1369-1381.
45. Meyer TJ, Mark MM Effects of psychosocial interventions with adult cancer patients: a meta-analysis of 116 studies. Oncol Nurs Forum. 1995;22:1369-1381.
46. Sheard T., Maguire P. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analysis. Br J Cancer. 1999;80:1770-1780.
47. Purohit DR, Navlakha PL, Modi RS, et al. The role antidepressants in hospitalized cancer patients. J Assoc Physicians India. 1978;26:245-248.
48. Holland JC, Romano SJ, Heiligenstein JH, et al. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology. 1998;7:291-300.
49. Eija K., Tiina T., Pertti NJ Amitriptuyline effectively relieves neuropathic pain following treatment of breast cancer. Pain. 1996;64:293-302.
50. Razavi D., Allilaire JF, Smith M., et al. The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand. 1996;94:205-210.
51. Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med. 2001;344:961-966.
52. Costa D., Mogos I., Toma T. Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand Suppl. 1985;320:85-92.
53. van Heeringen K., Zivkov M. Pharmacological treatment of depression in cancer patients: a placebo controlled study of mianserin. Br J Psychiatry. 1996;169:440-443.
54. Razavi D., Kormoss N., Collard A., et al. Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study. J Int Med Res. 1999;27:264-272.
55. Johnston B. Relief of mixed anxiety-depression in terminal cancer patients: effect of thioridazine. N Y State J Med. 1972; 72:2315-2317.
56. Bruera E., Roca E., Cedaro L., et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double blind study. Cancer Treat Rep. 1975;69:751-754.
57. Bruera E., Carraro S., Roca E., et al. Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients. Cancer Treat Rep. 1986;70:295-298.
58. Holland JC, Morrow GR, Schmale A., et al. A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol. 1991;9:1003-1011.
59. Katon W., Sullivan MD Depression and chronic medical illness. J Clin Psychiatry. 1990;51:3-11.
60. Lesko L., Massie M., Holland J. Oncology. In: Stoudemire A, Fogel B, eds. Principles of Medical Psychiatry. Orlando, FL: Grune & Stratton ; 1987:495-520.
61. Homsi J., Nelson KA, Sarhill N., et al. A phase II study of methylphenidate for depression in advanced cancer. Am J Hosp Palliat Care. 2001;18:403-407.